Reckitt Benckiser Group (LON:RB)‘s stock had its “neutral” rating reiterated by analysts at UBS Group in a research report issued on Thursday, Borsen Zeitung reports. They currently have a GBX 6,400 ($83.63) price objective on the stock. UBS Group’s price target would suggest a potential downside of 1.93% from the stock’s previous close.
Other research analysts also recently issued research reports about the stock. Bryan, Garnier & Co assumed coverage on shares of Reckitt Benckiser Group in a research note on Friday, April 5th. They issued a “neutral” rating and a GBX 6,800 ($88.85) price target on the stock. Jefferies Financial Group reaffirmed an “underperform” rating and issued a GBX 5,400 ($70.56) price target (up previously from GBX 5,000 ($65.33)) on shares of Reckitt Benckiser Group in a research note on Friday, April 5th. Goldman Sachs Group set a GBX 6,820 ($89.12) price target on shares of Reckitt Benckiser Group and gave the stock a “neutral” rating in a research note on Thursday, May 2nd. Royal Bank of Canada set a GBX 5,300 ($69.25) target price on shares of Reckitt Benckiser Group and gave the company a “sell” rating in a research report on Thursday, May 2nd. Finally, Shore Capital reissued an “under review” rating on shares of Reckitt Benckiser Group in a research report on Thursday, May 2nd. Three investment analysts have rated the stock with a sell rating, four have assigned a hold rating and eleven have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of GBX 7,154.12 ($93.48).
RB stock traded down GBX 83 ($1.08) during trading on Thursday, hitting GBX 6,526 ($85.27). The company had a trading volume of 1,766,260 shares, compared to its average volume of 1,720,000. The company has a market capitalization of $46.26 billion and a PE ratio of 21.41. Reckitt Benckiser Group has a 52-week low of GBX 5,559 ($72.64) and a 52-week high of GBX 7,174 ($93.74). The company has a debt-to-equity ratio of 80.49, a current ratio of 0.65 and a quick ratio of 0.47.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
Featured Story: Trading Strategy
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.